<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36353967</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-0496</ISSN><JournalIssue CitedMedium="Internet"><Volume>58</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Pediatric pulmonology</Title><ISOAbbreviation>Pediatr Pulmonol</ISOAbbreviation></Journal><ArticleTitle>COVID-19 and pediatric pulmonology: Feedback from an expert center after the first year of the pandemic.</ArticleTitle><Pagination><StartPage>392</StartPage><EndPage>397</EndPage><MedlinePgn>392-397</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/ppul.26235</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) outbreak has evolved with different waves corresponding to subsequent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutations. While the most severe cases have been observed in the elderly and in individuals with underlying comorbidities, severe pediatric and young adult cases have been observed, as well as post-infectious inflammatory syndromes and persistent symptoms leading to long-COVID. This manuscript describes the experience of a pediatric respiratory unit during the first year of the pandemic and reviews the corresponding literature with a special emphasis on children and young people with underlying conditions, such as immunosuppression, sickle cell disease, and cystic fibrosis.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Corvol</LastName><ForeName>Harriet</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-7026-7523</Identifier><AffiliationInfo><Affiliation>Service de Pneumologie P&#xe9;diatrique, Centre de R&#xe9;f&#xe9;rence des Maladies Respiratoires Rares RespiRare et Centre de Ressources et de Comp&#xe9;tences pour la Mucoviscidose, Sorbonne Universit&#xe9; et APHP, H&#xf4;pital Armand Trousseau, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de recherche Saint Antoine (CRSA), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prevost</LastName><ForeName>Blandine</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Service de Pneumologie P&#xe9;diatrique, Centre de R&#xe9;f&#xe9;rence des Maladies Respiratoires Rares RespiRare et Centre de Ressources et de Comp&#xe9;tences pour la Mucoviscidose, Sorbonne Universit&#xe9; et APHP, H&#xf4;pital Armand Trousseau, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de recherche Saint Antoine (CRSA), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aubertin</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Service de Pneumologie P&#xe9;diatrique, Centre de R&#xe9;f&#xe9;rence des Maladies Respiratoires Rares RespiRare et Centre de Ressources et de Comp&#xe9;tences pour la Mucoviscidose, Sorbonne Universit&#xe9; et APHP, H&#xf4;pital Armand Trousseau, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de recherche Saint Antoine (CRSA), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thouvenin</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Service de Pneumologie P&#xe9;diatrique, Centre de R&#xe9;f&#xe9;rence des Maladies Respiratoires Rares RespiRare et Centre de Ressources et de Comp&#xe9;tences pour la Mucoviscidose, Sorbonne Universit&#xe9; et APHP, H&#xf4;pital Armand Trousseau, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre de recherche Saint Antoine (CRSA), Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taytard</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-7552-3880</Identifier><AffiliationInfo><Affiliation>Service de Pneumologie P&#xe9;diatrique, Centre de R&#xe9;f&#xe9;rence des Maladies Respiratoires Rares RespiRare et Centre de Ressources et de Comp&#xe9;tences pour la Mucoviscidose, Sorbonne Universit&#xe9; et APHP, H&#xf4;pital Armand Trousseau, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inserm UMRS_S1158, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nathan</LastName><ForeName>Nadia</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-5149-7975</Identifier><AffiliationInfo><Affiliation>Service de Pneumologie P&#xe9;diatrique, Centre de R&#xe9;f&#xe9;rence des Maladies Respiratoires Rares RespiRare et Centre de Ressources et de Comp&#xe9;tences pour la Mucoviscidose, Sorbonne Universit&#xe9; et APHP, H&#xf4;pital Armand Trousseau, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Inserm UMR_S933, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Pulmonol</MedlineTA><NlmUniqueID>8510590</NlmUniqueID><ISSNLinking>1099-0496</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005246" MajorTopicYN="N">Feedback</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015272" MajorTopicYN="Y">Pulmonary Medicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">children</Keyword><Keyword MajorTopicYN="N">cystic fibrosis</Keyword><Keyword MajorTopicYN="N">immunosuppression</Keyword><Keyword MajorTopicYN="N">lung</Keyword><Keyword MajorTopicYN="N">sickle cell disease</Keyword></KeywordList><CoiStatement>The authors declare no conflict&#xa0;of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>10</Day><Hour>4</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36353967</ArticleId><ArticleId IdType="pmc">PMC9878247</ArticleId><ArticleId IdType="doi">10.1002/ppul.26235</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sant&#xe9; publique France. Chiffres cl&#xe9;s et &#xe9;volution de la COVID&#x2010;19 enFrance et dans le Monde. 2022. https://www.santepubliquefrance.fr/dossiers/coronavirus-covid-19/
</Citation></Reference><Reference><Citation>Cohen R, Jung C, Ouldali N, et al. Assessment of SARS&#x2010;CoV&#x2010;2 infection by reverse transcription&#x2010;PCR and serology in the Paris area: a cross&#x2010;sectional study. BMJ Paediatr&#xa0;Open. 2020;4(1):e000887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7778737</ArticleId><ArticleId IdType="pubmed">33665371</ArticleId></ArticleIdList></Reference><Reference><Citation>Harwood R, Yan H, Talawila Da Camara N, et al. Which children and young people are at higher risk of severe disease and death after hospitalisation with SARS&#x2010;CoV&#x2010;2 infection in children and young people: a systematic review and individual patient meta&#x2010;analysis. EClinicalMedicine. 2022;44:101287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8832134</ArticleId><ArticleId IdType="pubmed">35169689</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID&#x2010;19) outbreak in China: summary of a report of 72&#x202f;314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239&#x2010;1242.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan N, Prevost B, Lambert S, Schnuriger A, Corvol H. Severe acute respiratory syndrome coronavirus 2 variant Delta infects all 6 siblings but spares comirnaty (BNT162b2, BioNTech/Pfizer)&#x2010;vaccinated parents. J Infect Dis. 2021;224(11):1984&#x2010;1986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8499735</ArticleId><ArticleId IdType="pubmed">34409999</ArticleId></ArticleIdList></Reference><Reference><Citation>Taytard J, Prevost B, Corvol H. More on BNT162b2 Covid&#x2010;19 vaccine in children 5 to 11 years of age. N Engl J Med. 2022;386(12):1191&#x2010;1193.</Citation><ArticleIdList><ArticleId IdType="pubmed">35235722</ArticleId></ArticleIdList></Reference><Reference><Citation>Taytard J, Prevost B, Schnuriger A, et al. SARS&#x2010;CoV&#x2010;2 B.1.1.529 (Omicron) variant causes an unprecedented surge in children hospitalizations and distinct clinical presentation compared to the SARS&#x2010;CoV&#x2010;2 B.1.617.2 (Delta) variant. Front Pediatr. 2022;10:932170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9271577</ArticleId><ArticleId IdType="pubmed">35832582</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdukahil SA, Abe R, Abel L, et al. COVID&#x2010;19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study. Infection. 2021;49(5):889&#x2010;905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8231091</ArticleId><ArticleId IdType="pubmed">34170486</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourgeois FT, Guti&#xe9;rrez&#x2010;Sacrist&#xe1;n A, Keller MS, et al. International analysis of electronic health records of children and youth hospitalized with COVID&#x2010;19 infection in 6 countries. JAMA Network Open. 2021;4(6):e2112596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8196345</ArticleId><ArticleId IdType="pubmed">34115127</ArticleId></ArticleIdList></Reference><Reference><Citation>Thouvenin G, Prevost B, Corvol H. The omicron wave modifies the COVID&#x2010;19 paradigm in children with cystic fibrosis. J Infect Dis. 2022:jiac328. 10.1093/infdis/jiac328</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac328</ArticleId><ArticleId IdType="pmc">PMC9384553</ArticleId><ArticleId IdType="pubmed">35906931</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID&#x2010;19 among children in China. Pediatrics. 2020;145(6):e20200702.</Citation><ArticleIdList><ArticleId IdType="pubmed">32179660</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan N, Prevost B, Sileo C, et al. The wide spectrum of COVID&#x2010;19 clinical presentation in children. J Clin Med. 2020;9(9):2950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7564665</ArticleId><ArticleId IdType="pubmed">32932612</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang A, Chorath K, Moreira A, et al. COVID&#x2010;19 in 7780 pediatric patients: a systematic review. EClinicalMedicine. 2020;24:100433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318942</ArticleId><ArticleId IdType="pubmed">32766542</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalyanaraman M, Anderson MR. COVID&#x2010;19 in children. Pediatr Clin North Am. 2022;69(3):547&#x2010;571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8808705</ArticleId><ArticleId IdType="pubmed">35667761</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS&#x2010;CoV&#x2010;2 and COVID&#x2010;19. Nat Rev Microbiol. 2021;19(3):141&#x2010;154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang JG, Zhong ZJ, Mo YF, Wang LC, Chen R. Epidemiological features of coronavirus disease 2019 in children: a meta&#x2010;analysis. Eur Rev Med Pharmacol Sci. 2021;25(2):1146&#x2010;1157.</Citation><ArticleIdList><ArticleId IdType="pubmed">33577071</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskander E, Levy C, Batard C, et al. Infection SARS CoV&#x2010;2 en ambulatoire chez l'enfant. Perfectionnement en P&#xe9;diatrie. 2021;4(2, Suppl 1):E3&#x2010;E4.</Citation></Reference><Reference><Citation>Graff K, Smith C, Silveira L, et al. Risk factors for severe COVID&#x2010;19 in children. Pediatr Infect Dis J. 2021;40(4):e137&#x2010;e145.</Citation><ArticleIdList><ArticleId IdType="pubmed">33538539</ArticleId></ArticleIdList></Reference><Reference><Citation>Nathan N, Prevost B, Corvol H. Atypical presentation of COVID&#x2010;19 in young infants. Lancet. 2020;395(10235):1481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185921</ArticleId><ArticleId IdType="pubmed">32353326</ArticleId></ArticleIdList></Reference><Reference><Citation>Mark EG, Golden WC, Gilmore MM, et al. Community&#x2010;onset severe acute respiratory syndrome coronavirus 2 infection in young infants: a systematic review. J Pediatr. 2021;228:94&#x2010;100.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477627</ArticleId><ArticleId IdType="pubmed">32910943</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouldali N, Yang DD, Madhi F, et al. Factors associated with severe SARS&#x2010;CoV&#x2010;2 infection. Pediatrics. 2021;147(3):e2020023432.</Citation><ArticleIdList><ArticleId IdType="pubmed">33323493</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann P, Curtis N. Coronavirus infections in children including COVID&#x2010;19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J. 2020;39(5):355&#x2010;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158880</ArticleId><ArticleId IdType="pubmed">32310621</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff RC, Campbell AP, Taylor CA, et al. Risk factors for severe COVID&#x2010;19 in children. Pediatrics. 2022;149(1):e2021053418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9213563</ArticleId><ArticleId IdType="pubmed">34935038</ArticleId></ArticleIdList></Reference><Reference><Citation>Pr&#xe9;vost B, Retbi A, Binder&#x2010;Foucard F, et al. Risk factors for admission to the pediatric critical care unit among children hospitalized with COVID&#x2010;19 in France. Front Pediatr. 2022;10:975826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9489832</ArticleId><ArticleId IdType="pubmed">36160797</ArticleId></ArticleIdList></Reference><Reference><Citation>Chima M, Williams D, Thomas NJ, Krawiec C. COVID&#x2010;19&#x2010;Associated pulmonary embolism in pediatric patients. Hosp&#xa0;Pediatr. 2021;11(6):e90&#x2010;e94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10472622</ArticleId><ArticleId IdType="pubmed">33785517</ArticleId></ArticleIdList></Reference><Reference><Citation>Odi&#xe8;vre MH, de Marcellus C, Ducou Le Pointe H, et al. Dramatic improvement after tocilizumab of severe COVID&#x2010;19 in a child with sickle cell disease and acute chest syndrome. Am J Hematol. 2020;95(8):E192&#x2010;E194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267654</ArticleId><ArticleId IdType="pubmed">32358817</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrams JY, Oster ME, Godfred&#x2010;Cato SE, et al. Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS&#x2010;C) in the USA: a retrospective surveillance study. Lancet Child&#xa0;Adolesc&#xa0;Health. 2021;5(5):323&#x2010;331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7943393</ArticleId><ArticleId IdType="pubmed">33711293</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies P, Evans C, Kanthimathinathan HK, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS&#x2010;CoV&#x2010;2 (PIMS&#x2010;TS) in the UK: a multicentre observational study. Lancet Child Adolesc Health. 2020;4(9):669&#x2010;677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347350</ArticleId><ArticleId IdType="pubmed">32653054</ArticleId></ArticleIdList></Reference><Reference><Citation>Toubiana J, Poirault C, Corsia A, et al. Kawasaki&#x2010;like multisystem inflammatory syndrome in children during the covid&#x2010;19 pandemic in Paris, France: prospective observational study. BMJ. 369, 2020:m2094.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7500538</ArticleId><ArticleId IdType="pubmed">32493739</ArticleId></ArticleIdList></Reference><Reference><Citation>Blondiaux E, Parisot P, Redheuil A, et al. Cardiac MRI in children with multisystem inflammatory syndrome associated with COVID&#x2010;19. Radiology. 2020;297(3):E283&#x2010;E288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7294821</ArticleId><ArticleId IdType="pubmed">32515676</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo&#x2010;Pujol J, Moron&#x2010;Lopez S, Dalmau J, et al. Post COVID&#x2010;19 condition in children and adolescents: an emerging problem. Front Pediatr. 2022;10:894204.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9130634</ArticleId><ArticleId IdType="pubmed">35633949</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez&#x2010;Leon S, Wegman&#x2010;Ostrosky T, Ayuzo Del Valle NC, et al. Long&#x2010;COVID in children and adolescents: a systematic review and meta&#x2010;analyses. Sci Rep. 2022;12(1):9950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post&#x2010;COVID&#x2010;19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2010;e107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, et al. Risk factors for post&#x2010;COVID&#x2010;19 condition in previously hospitalised children using the ISARIC Global follow&#x2010;up protocol: a prospective cohort study. Eur Respir J. 2022;59(2):2101341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Moeller A, Thanikkel L, Duijts L, et al. COVID&#x2010;19 in children with underlying chronic respiratory diseases: survey results from 174 centres. ERJ Open Res. 2020;6(4):00409&#x2010;2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682706</ArticleId><ArticleId IdType="pubmed">33263054</ArticleId></ArticleIdList></Reference><Reference><Citation>Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID&#x2010;19) infection admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr. 2020;174(9):868&#x2010;873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489842</ArticleId><ArticleId IdType="pubmed">32392288</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez&#x2010;Dambrauskas S, V&#xe1;squez&#x2010;Hoyos P, Camporesi A, et al. Pediatric critical care and COVID&#x2010;19. Pediatrics. 2020;146(3):e20201766.</Citation><ArticleIdList><ArticleId IdType="pubmed">32518171</ArticleId></ArticleIdList></Reference><Reference><Citation>Bixler D, Miller AD, Mattison CP, et al. SARS&#x2010;CoV&#x2010;2&#x2010;associated deaths among persons aged &lt;21 years&#x2014;United States, February 12&#x2010;July 31, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1324&#x2010;1329.</Citation><ArticleIdList><ArticleId IdType="pubmed">32941417</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha RS. Challenges posed by COVID&#x2010;19 to children with cancer. Lancet Oncol. 2020;21(5):e235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270527</ArticleId><ArticleId IdType="pubmed">32220660</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamperlini&#x2010;Netto G, Fernandes JF, Garcia JL, et al. COVID&#x2010;19 after hematopoietic stem cell transplantation: report of two children. Bone Marrow Transplant. 2021;56(3):713&#x2010;715.</Citation><ArticleIdList><ArticleId IdType="pubmed">32934304</ArticleId></ArticleIdList></Reference><Reference><Citation>Feldman AG, Danziger&#x2010;Isakov LA. The impact of COVID&#x2010;19 on the pediatric solid organ transplant population. Semin Pediatr Surg. 2022;31(3):151178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9107330</ArticleId><ArticleId IdType="pubmed">35725046</ArticleId></ArticleIdList></Reference><Reference><Citation>Cesaro S, Ljungman P, Mikulska M, et al. Recommendations for the management of COVID&#x2010;19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9). Leukemia. 2022;36(6):1467&#x2010;1480.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9053562</ArticleId><ArticleId IdType="pubmed">35488021</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang W, Guan W, Chen R, et al. Cancer patients in SARS&#x2010;CoV&#x2010;2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335&#x2010;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159000</ArticleId><ArticleId IdType="pubmed">32066541</ArticleId></ArticleIdList></Reference><Reference><Citation>Corvol H, Alimi A, Prevost B, et al. Atypical severe organizing pneumonia following coronavirus disease 2019 in an immunocompromised teenager. Clin Infect Dis. 2022;74(5):938&#x2010;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">34309637</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoogenboom WS, Alamuri TT, McMahon DM, et al. Clinical outcomes of COVID&#x2010;19 in patients with sickle cell disease and sickle cell trait: a critical appraisal of the literature. Blood Rev. 2022;53:100911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8605823</ArticleId><ArticleId IdType="pubmed">34838342</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaincre&#x2010;la&#x2010;Mucoviscidose . Registre Fran&#xe7;ais de la mucoviscidose &#x2010; Bilan des donn&#xe9;es 2018. 2020.</Citation></Reference><Reference><Citation>Corvol H, de Miranda S, Lemonnier L, et al. First wave of COVID&#x2010;19 in French patients with cystic fibrosis. J Clin Med. 2020;9(11):3624.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7697588</ArticleId><ArticleId IdType="pubmed">33182847</ArticleId></ArticleIdList></Reference><Reference><Citation>Corvol H, de Miranda S, Dehillotte C, et al. Cumulative incidence and risk factors for severe COVID&#x2010;19 in French people with cystic fibrosis. Clin Infect Dis. 2022:ciac333. 10.1093/cid/ciac333</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac333</ArticleId><ArticleId IdType="pmc">PMC9129125</ArticleId><ArticleId IdType="pubmed">35475917</ArticleId></ArticleIdList></Reference><Reference><Citation>McClenaghan E, Cosgriff R, Brownlee K, et al. The global impact of SARS&#x2010;CoV&#x2010;2 in 181 people with cystic fibrosis. J&#xa0;Cyst&#xa0;Fibros. 2020;19(6):868&#x2010;871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7641525</ArticleId><ArticleId IdType="pubmed">33183965</ArticleId></ArticleIdList></Reference><Reference><Citation>Bain R, Cosgriff R, Zampoli M, et al. Clinical characteristics of SARS&#x2010;CoV&#x2010;2 infection in children with cystic fibrosis: an international observational study. J&#xa0;Cyst&#xa0;Fibros. 2021;20(1):25&#x2010;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7713571</ArticleId><ArticleId IdType="pubmed">33309057</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Mo Y, Su Y, et al. Computed tomography features of COVID&#x2010;19 in children: A systematic review and meta&#x2010;analysis. Medicine. 2021;100(38):e22571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8462638</ArticleId><ArticleId IdType="pubmed">34559092</ArticleId></ArticleIdList></Reference><Reference><Citation>Waller JV, Lin KK, Diaz MJ, et al. CT presentations of adult and pediatric SARS&#x2010;CoV&#x2010;2 patients: a review of early COVID&#x2010;19 data. Radiolog&#xed;a (Eng&#xa0;Ed). 2021;63(6):495&#x2010;504.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8416688</ArticleId><ArticleId IdType="pubmed">34801182</ArticleId></ArticleIdList></Reference><Reference><Citation>Ucan B, Kaynak Sahap S, Cinar HG, et al. Multisystem inflammatory syndrome in children associated with SARS&#x2010;CoV&#x2010;2: extracardiac radiological findings. Br J Radiol. 2022;95(1129):20210570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8722242</ArticleId><ArticleId IdType="pubmed">34889647</ArticleId></ArticleIdList></Reference><Reference><Citation>
COVID&#x2010;19 Treatment Guidelines Panel
. Coronavirus Disease 2019 (COVID&#x2010;19) Treatment Guidelines. National Institutes of Health. https://www.covid19treatmentguidelines.nih.gov/
</Citation><ArticleIdList><ArticleId IdType="pubmed">34003615</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter EB, Talaat KR, Sabharwal C, et al. Evaluation of the BNT162b2 Covid&#x2010;19 vaccine in children 5 to 11 years of age. N Engl J Med. 2022;386(1):35&#x2010;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8609605</ArticleId><ArticleId IdType="pubmed">34752019</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerber JS, Offit PA. COVID&#x2010;19 vaccines for children. Science. 2021;374(6570):913.</Citation><ArticleIdList><ArticleId IdType="pubmed">34793207</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>